Search for: "Par Pharmaceutical, Inc."
Results 21 - 40
of 147
Sorted by Relevance
|
Sort by Date
4 Dec 2014, 10:00 pm
In Par Pharmaceutical Inc. v. [read post]
2 Jul 2007, 9:44 pm
(which was acquired by Par Pharmaceutical in June of 2004). [read post]
12 Sep 2015, 8:01 am
Robinson in Par Pharmaceutical, Inc., et al. v. [read post]
29 May 2009, 1:10 pm
The Federal Court recently issued its judgment in NPS Pharmaceuticals, Inc v. [read post]
29 Sep 2017, 12:26 pm
IPOs and offerings of small pharmaceutical companies are incredibly risky – on par with the risks of penny stocks. [read post]
5 Sep 2012, 5:45 pm
California - The Federal Circuit on Tuesday gave Santarus Inc. another chance to prove that its patents for the heartburn drug Zegerid are valid and that Par Pharmaceuticals Inc.'s proposed generic version would infringe those patents. [read post]
12 May 2010, 5:49 pm
The members of the Creditors' Committee are: Par Pharmaceutical, Inc. [read post]
18 Oct 2012, 1:00 am
Par Pharmaceutical Inc., the Federal Circuit upheld the district court’s determination that the patents at issue were not invalid as obvious and were infringed by the subject Abbreviated New Drug Applications (ANDAs). [read post]
18 Oct 2008, 8:19 am
In the Hatch-Waxman area, Pozen, Inc. announced Par Pharmaceutical Inc. has filed an application with the Food and Drug Administration [FDA] to make a generic version of Treximet, a migraine treatment Pozen developed with GlaxoSmithKline PLC, and shares of Pozen shed nearly 28 percent of their value on 17 Oct. 08 [read post]
9 Sep 2011, 6:56 am
Par Pharmaceutical Cos., 06-6131, US District Court, Northern District of Illinois (Chicago). [read post]
26 Jan 2016, 11:23 am
**As one small footnote, Ampyra is not a disease-modifying treatment for MS, in contrast to Copaxone or Tecfidera.link to BNA report: http://www.bna.com/acorda-par-settle-n57982066522/ [read post]
19 Apr 2012, 8:17 pm
Inc. v. [read post]
15 Sep 2009, 9:55 pm
By Suresh Pillai -- Purdue Files Appeal in Ultram ® Suit against Par Purdue Pharma Products Inc. has filed an appeal with the U.S. [read post]
16 Sep 2021, 12:57 pm
Suffolk and Nassau Counties will each receive $13.85 million in combined settlements from Endo and its subsidiary Par Pharmaceutical, Inc. [read post]
19 Apr 2009, 7:13 pm
Par Pharmaceutical, Inc. v. [read post]
24 Oct 2017, 4:15 am
See Par Pharmaceutical, Inc. v. [read post]
20 May 2015, 1:00 am
Wall Street Journal, Rules Fail To Rein In Tax-Driven Takeovers: Endo International PLC agreed to buy rival drug maker Par Pharmaceutical Holdings Inc. for $8 billion, the latest in a string of cross-border mergers steering tax revenue away from the U.S., despite Washington’s efforts. [read post]
28 Oct 2007, 9:50 pm
Par Pharmaceutical Inc. et al. 1:07-cv-00666; filed October 24, 2007 in the... [read post]
13 May 2007, 5:18 pm
Par Pharmaceuticals Inc. et. al.1:07-cv-00255; filed May 9, 2007 in the District... [read post]
19 Oct 2012, 6:13 pm
The majority of the assets in these 18 markets would be divested to Par Pharmaceutical, Inc. [read post]
